Video

Minaris Advanced Therapies Capacity Update October 2025: Cell & Gene Therapy

Minaris Advanced Therapies is a global CDMO and testing organization dedicated to advancing cell and gene therapies from development through commercial supply. With decades of experience, over 7,500 GMP batch releases, and commercial-ready facilities spanning three continents, we bring unmatched scale and expertise to our partners.

During this session, we will provide an overview of our capabilities, including our contract testing services, and an update on our current capacity.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Minaris Advanced Therapies